Get a Quote

Abacavir Sulfate API (CAS 188062-50-2)
CAS NO.: 188062-50-2
Chemical Formula: C14H18N6O • 0.5 H2SO4
Molecular Weight: 335.3700
DMF&GMP status: Available
Description:
Abacavir (ABC) is an antiretroviral medication used to prevent and treat HIV/AIDS. The chemical name of Abacavir Sulfate is (1S, order cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol sulfate (salt) (2:1). Abacavir Sulfate is the enantiomer with 1S , 4R absolute configuration on the cyclopentene ring. Abacavir Sulfate is always used with other anti-HIV-1 medicines. When used in combination with these other medicines, Abacavir Sulfate helps lower the amount of HIV-1 found in the blood.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
ABACAVIR SULFATESOLUTION;ORALEQ 20MG BASE/MLZIAGENVIIV HLTHCARE
ABACAVIR SULFATETABLET;ORAL EQ 300MG BASE ABACAVIR SULFATE APOTEX INC
ABACAVIR SULFATETABLET;ORAL EQ 300MG BASE ABACAVIR SULFATE AUROBINDO PHARMA LTD
ABACAVIR SULFATETABLET;ORAL EQ 300MG BASE ABACAVIR SULFATE HETERO LABS LTD III
ABACAVIR SULFATETABLET;ORAL EQ 300MG BASE ABACAVIR SULFATE MYLAN PHARMS INC
ABACAVIR SULFATE TABLET;ORAL EQ 300MG BASE ZIAGEN VIIV HLTHCARE
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINETABLET;ORAL EQ 600MG BASE; EQ 50MG BASE; 300MG TRIUMEQ VIIV HLTHCARE
ABACAVIR SULFATE; LAMIVUDINETABLET;ORAL EQ 600MG BASE; 300MG EPZICOM VIIV HLTHCARE
ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINETABLET; ORAL EQ 300MG BASE; 150MG; 300MG ABACAVIR SULFATE;LAMIVUDINE AND ZIDOVUDINE LUPIN LTD
ABACAVIR SULFATE; LAMIVUDINE; ZIDTABLET;ORAL EQ 300MG BASE; 150MG; 300MG TRIZIVIR VIIV HLTHCARE
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
6294540May 14. 2018YYU - 65
6641843 Feb 4. 2019 Y
5905082 May 18. 2016 Y Y
6417191 Mar 28. 2016 Y U - 1572
8129385 Oct 5. 2027 Y Y
9242986 Dec 8. 2029 Y Y
Exclusive Data
Exclusivity Code Exclusivity Expiration
NCE (NEW CHEMICAL ENTITY) Aug 12. 2018
D - 147 (ONCE DAILY DOSING IN PEDIATRIC PATIENTS 3 MONTHS OF AGE AND OLDER IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION) Mar 23. 2018